TELA Bio annual depreciation and amortization
2017
2018
2019
2020
2021
2022
2023
2024
2025
TELA Bio Depreciation & Amortization Growth & History (TELA)
TELA Bio's depreciation and amortization was $630,000 for fiscal 2025.
View full TELA Bio company overviewTELA Bio annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $630,000 | −$2,000 | −0.32% |
| 2024 | 2024-12-31 | $632,000 | $204,000 | +47.66% |
| 2023 | 2023-12-31 | $428,000 | $45,000 | +11.75% |
| 2022 | 2022-12-31 | $383,000 | $152,000 | +65.80% |
| 2021 | 2021-12-31 | $231,000 | $10,000 | +4.52% |
| 2020 | 2020-12-31 | $221,000 | −$57,000 | −20.50% |
| 2019 | 2019-12-31 | $278,000 | −$185,000 | −39.96% |
| 2018 | 2018-12-31 | $463,000 | −$298,000 | −39.16% |
| 2017 | 2017-12-31 | $761,000 | — | — |
TELA Bio quarterly depreciation and amortization
Q1.19
Q2.19
Q3.19
Q1.20
Q2.20
Q3.20
Q1.21
Q2.21
Q3.21
Q1.22
Q2.22
Q3.22
Q1.23
Q2.23
Q3.23
Q1.24
Q2.24
Q3.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $171,000 | −$4,000 | −2.29% |
| Q1 2026 | 2026-03-31 | $169,000 | −$3,000 | −1.74% |
| Q4 2025 | 2025-12-31 | $225,000 | — | — |
| Q3 2025 | 2025-09-30 | $153,000 | −$15,000 | −8.93% |
| Q2 2025 | 2025-06-30 | $175,000 | $21,000 | +13.64% |
| Q1 2025 | 2025-03-31 | $172,000 | $33,000 | +23.74% |
| Q3 2024 | 2024-09-30 | $168,000 | $45,000 | +36.59% |
| Q2 2024 | 2024-06-30 | $154,000 | $35,000 | +29.41% |
| Q1 2024 | 2024-03-31 | $139,000 | $19,000 | +15.83% |
| Q3 2023 | 2023-09-30 | $123,000 | $13,000 | +11.82% |
| Q2 2023 | 2023-06-30 | $119,000 | $36,000 | +43.37% |
| Q1 2023 | 2023-03-31 | $120,000 | $42,000 | +53.85% |
| Q3 2022 | 2022-09-30 | $110,000 | $59,000 | +115.69% |
| Q2 2022 | 2022-06-30 | $83,000 | $28,000 | +50.91% |
| Q1 2022 | 2022-03-31 | $78,000 | $14,000 | +21.88% |
| Q3 2021 | 2021-09-30 | $51,000 | −$12,000 | −19.05% |
| Q2 2021 | 2021-06-30 | $55,000 | $16,000 | +41.03% |
| Q1 2021 | 2021-03-31 | $64,000 | $8,000 | +14.29% |
| Q3 2020 | 2020-09-30 | $63,000 | −$8,000 | −11.27% |
| Q2 2020 | 2020-06-30 | $39,000 | −$26,000 | −40.00% |
| Q1 2020 | 2020-03-31 | $56,000 | −$14,000 | −20.00% |
| Q3 2019 | 2019-09-30 | $71,000 | — | — |
| Q2 2019 | 2019-06-30 | $65,000 | — | — |
| Q1 2019 | 2019-03-31 | $70,000 | — | — |
TELA Bio depreciation and amortization trends
Over the last five fiscal years, TELA Bio's depreciation and amortization increased from $221,000 to $630,000, a change of $409,000. The latest reported quarter, Q2 2026, shows $171,000.
About the metric
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Calculation and source
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review TELA Bio source filings ↗